These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Visual fields in young children treated with vigabatrin. Agrawal S, Mayer DL, Hansen RM, Fulton AB. Optom Vis Sci; 2009 Jun; 86(6):767-73. PubMed ID: 19417698 [Abstract] [Full Text] [Related]
30. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose. Kinirons P, Cavalleri GL, O'Rourke D, Doherty CP, Reid I, Logan P, Liggan B, Delanty N. Epilepsia; 2006 Feb; 47(2):311-7. PubMed ID: 16499754 [Abstract] [Full Text] [Related]
31. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. Wild JM, Chiron C, Ahn H, Baulac M, Bursztyn J, Gandolfo E, Goldberg I, Goñi FJ, Mercier F, Nordmann JP, Safran AB, Schiefer U, Perucca E. CNS Drugs; 2009 Nov; 23(11):965-82. PubMed ID: 19845417 [Abstract] [Full Text] [Related]
36. Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication. Hardus P, Verduin WM, Postma G, Stilma JS, Berendschot TT, van Veelen CW. Epilepsia; 2000 May; 41(5):581-7. PubMed ID: 10802764 [Abstract] [Full Text] [Related]
38. [Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis]. Rotta NT, da Silva AR, Ohlweiler L, Riesgo R. Arq Neuropsiquiatr; 2003 Dec; 61(4):988-90. PubMed ID: 14762603 [Abstract] [Full Text] [Related]